{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:38Z","timestamp":1789609118700,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":2525,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1111\/ajt.13444","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T16:52:55Z","timestamp":1442335975000},"page":"157-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"title":["ABO-Incompatible Adult Living Donor Liver Transplantation Under the Desensitization Protocol With Rituximab"],"prefix":"10.1016","volume":"16","author":[{"given":"G.-W.","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-S.","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.-B.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.-Y.","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.-H.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.-C.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.-J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-H.","family":"Sin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-I.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.-H.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.-Y.","family":"Tak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.13444_bib1","first-page":"342","article-title":"Liver transplantation across ABO blood groups","volume":"100","author":"Gordon","year":"1986","journal-title":"Surgery"},{"key":"10.1111\/ajt.13444_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0140-6736(90)92082-S","article-title":"Liver transplantation across ABO blood group barriers","volume":"336","author":"Gugenheim","year":"1990","journal-title":"Lancet"},{"key":"10.1111\/ajt.13444_bib3","first-page":"489","article-title":"Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers","volume":"132","author":"Demetris","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1111\/ajt.13444_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00595-010-4437-3","article-title":"Management of ABO-incompatible living-donor liver transplantation: Past and present trends","volume":"41","author":"Raut","year":"2011","journal-title":"Surg Today"},{"key":"10.1111\/ajt.13444_bib5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/ajt.12520","article-title":"Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: A Japanese multicenter study","volume":"14","author":"Egawa","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13444_bib6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2014.04.039","article-title":"Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era","volume":"61","author":"Song","year":"2014","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.13444_bib7","doi-asserted-by":"crossref","first-page":"e16521","DOI":"10.1371\/journal.pone.0016521","article-title":"Recipient outcomes after ABO-incompatible liver transplantation: A systematic review and meta-analysis","volume":"6","author":"Wu","year":"2011","journal-title":"PLoS One"},{"issue":"Suppl 8","key":"10.1111\/ajt.13444_bib8","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1097\/01.tp.0000446279.81922.dd","article-title":"Section 15. A desensitizing protocol without local graft infusion therapy and splenectomy is a safe and effective method in ABO-incompatible adult LDLT","volume":"97","author":"Song","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13444_bib9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/lt.21092","article-title":"B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation","volume":"13","author":"Egawa","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13444_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00534-007-1298-2","article-title":"Current status of liver transplantation across ABO blood-type barrier","volume":"15","author":"Egawa","year":"2008","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1111\/ajt.13444_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.TP.0000110295.88926.5C","article-title":"Impact of recipient age on outcome of ABO incompatible living-donor liver transplantation","volume":"77","author":"Egawa","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13444_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/lt.20002","article-title":"Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation","volume":"10","author":"Haga","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13444_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/lt.20652","article-title":"Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation","volume":"12","author":"Haga","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13444_bib14","first-page":"495","article-title":"Ischemic cholangiopathy after liver transplantation","volume":"4","author":"Cameron","year":"2005","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1111\/ajt.13444_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/s-0028-1085092","article-title":"Ischemic cholangiopathy","volume":"28","author":"Deltenre","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1111\/ajt.13444_bib16","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/lt.20734","article-title":"Lessons learned from 1,000 living donor liver transplantations in a single center: How to make living donations safe","volume":"12","author":"Hwang","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13444_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.21928","article-title":"Present status of ABO-incompatible living donor liver transplantation in Japan","volume":"47","author":"Egawa","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/ajt.13444_bib18","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jhep.2013.07.035","article-title":"ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor","volume":"59","author":"Kim","year":"2013","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.13444_bib19","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1016\/j.transproceed.2008.03.174","volume":"40","author":"Kim","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.13444_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/TP.0b013e3181adcae6","article-title":"Rituximab, IVIG, and plasma exchange without graft local infusion treatment: A new protocol in ABO incompatible living donor liver transplantation","volume":"88","author":"Ikegami","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13444_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-6143.2006.01632.x","article-title":"The effect of desensitization protocols on human splenic B-cell populations in vivo","volume":"7","author":"Ramos","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13444_bib22","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/TP.0b013e31823be816","article-title":"Rescue splenectomy in a case of humoral rejection in ABO-incompatible simultaneous liver-kidney transplantation","volume":"93","author":"Tzvetanov","year":"2012","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13444_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/TP.0b013e318239e8e4","article-title":"Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab","volume":"93","author":"Raut","year":"2012","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13444_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1432-2277.2008.00821.x","article-title":"Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients","volume":"22","author":"Toki","year":"2009","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.13444_bib25","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/j.1600-6143.2006.01497.x","article-title":"Pharmacodynamics of rituximab in kidney allotransplantation","volume":"6","author":"Genberg","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13444_bib26","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1097\/TP.0b013e318231e9f8","article-title":"Kinetics of anti-blood type isoagglutinin titers and B lymphocytes in ABO-incompatible living donor liver transplantation with rituximab and plasma exchange","volume":"92","author":"Uchiyama","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13444_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/asheducation.V2012.1.7.3797920","article-title":"Plasma exchange: Concepts, mechanisms, and an overview of the American Society for Apheresis guidelines","volume":"2012","author":"Winters","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/ajt.13444_bib28","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1538-7836.2010.03818.x","article-title":"Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura","volume":"8","author":"McDonald","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/ajt.13444_bib29","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/bcp.12098","article-title":"Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease","volume":"76","author":"Puisset","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/ajt.13444_bib30","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1309\/RLNMJ01WBJRNLH03","article-title":"Rituximab can be combined with daily plasma exchange to achieve effective B-cell depletion and clinical improvement in acute autoimmune TTP","volume":"125","author":"Darabi","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/ajt.13444_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.trim.2014.11.216","article-title":"Kinetics of B, T, NK lymphocytes and isoagglutinin titers in ABO incompatible living donor liver transplantation using rituximab and basiliximab","volume":"32","author":"Lee","year":"2015","journal-title":"Transpl Immunol"},{"key":"10.1111\/ajt.13444_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1399-0012.2005.00470.x","article-title":"ABO-incompatible deceased donor liver transplantation with the use of antigenspecificimmunoadsorption and anti-CD20 monoclonal antibody","volume":"20","author":"Boberg","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1111\/ajt.13444_bib33","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/jca.21244","article-title":"Emergency ABO-incompatible liver transplant secondary to fulminant hepatic failure: Outcome, role of TPE and review of the literature","volume":"27","author":"Maitta","year":"2012","journal-title":"J Clin Apher"},{"key":"10.1111\/ajt.13444_bib34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1499-3872(14)60268-X","article-title":"A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure","volume":"13","author":"Shen","year":"2014","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1111\/ajt.13444_bib35","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/lt.23789","article-title":"Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation","volume":"20","author":"Salah","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13444_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2559.2007.02677.x","article-title":"C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status","volume":"50","author":"Bellamy","year":"2007","journal-title":"Histopathology"},{"key":"10.1111\/ajt.13444_bib37","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1600-6143.2005.01180.x","article-title":"C4d in acute rejection after livertransplantation\u2014a valuable tool in differential diagnosisto hepatitis C recurrence","volume":"6","author":"Schmeding","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13444_bib38","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/00007890-199504150-00011","article-title":"Successful use of an enhanced immunosuppressive protocol with plasmapheresis for ABO-incompatible mismatched grafts in liver transplant recipients","volume":"59","author":"Mor","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13444_bib39","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1399-3089.2006.00286.x","article-title":"Adult ABO-incompatible liver transplantation, using A and B donors","volume":"13","author":"Skogsberg","year":"2006","journal-title":"Xenotransplantation"},{"key":"10.1111\/ajt.13444_bib40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","article-title":"Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production","volume":"9","author":"Perry","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13444_bib41","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1097\/TP.0b013e3181fdd9b0","article-title":"The role of proteasome inhibition with bortezomib in the treatment of antibody-mediated rejection after kidney-only or kidney-combined organ transplantation","volume":"90","author":"Flechner","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13444_bib42","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1016\/j.transproceed.2012.02.037","article-title":"The use of bortezomib as a rescue treatment for acute antibody-mediated rejection: Report of three cases and review of literature","volume":"44","author":"Tzvetanov","year":"2012","journal-title":"Transplant Proc"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.13444","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.13444","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.13444","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522005214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522005214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.13444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:27:22Z","timestamp":1761625642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522005214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1600613522005214"],"URL":"https:\/\/doi.org\/10.1111\/ajt.13444","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ABO-Incompatible Adult Living Donor Liver Transplantation Under the Desensitization Protocol With Rituximab","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.13444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}